Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Timothy M. Mayleben currently holds 10,450 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy M. Mayleben has been a net seller of ESPR stock. They have purchased $2.5M and sold $2.8M worth of shares.
Timothy M. Mayleben's most recent insider trade was on Jun 18, 2024, when they sold 10,450 shares at $0.00 per share.
Timothy M. Mayleben serves as Executive at Esperion Therapeutics, Inc. (ESPR). They have executed 54 insider transactions totaling $5.4M over their tenure at the company.
Timothy M. Mayleben holds the position of Executive at Esperion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Timothy M. Mayleben has shown a selling trading pattern, with $2.5M in total purchases and $2.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Timothy M. Mayleben was on Jun 8, 2018, when they sold $1.8M worth of LOXO shares. This transaction involved 10,000 shares at $179.55 per share.
Timothy M. Mayleben currently owns 10,450 shares of Esperion Therapeutics, Inc. (ESPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Timothy M. Mayleben's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Timothy M. Mayleben has 54 Form 4 filings on record as an insider at Esperion Therapeutics, Inc..
Set alerts for Timothy M. Mayleben and 40,000+ other insiders.